Other News

Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.

Hillrom Advances Digital Health Offering With Expansion Into Attractive Ambulatory Cardiac Monitoring Segment CHICAGO, Jan. 19, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies. Under the terms of […]

DiNAQOR Acquires EHT Technologies GmbH to Advance Engineered Heart Tissue R&D Capabilities

PFÄFFIKON, Switzerland, Jan. 19, 2021 /PRNewswire/ — DiNAQOR, a gene therapy platform company, today announced that it has acquired EHT Technologies GmbH, a Germany-based engineered heart tissue (EHT) technology platform company. Financial terms of the transaction were not disclosed. EHT Technologies was founded in 2015 based upon research on human induced pluripotent stem cells (hiPSC) at […]

2-French Electrophysiology Microcatheter Launches in Europe, Enabling Deeper Coronary Sinus Mapping

TORONTO, Jan. 19, 2021 /PRNewswire/ — Baylis Medical announced today the launch and first clinical case in Europe of the JLL 2-French electrophysiology microcatheter, performed by Dr. Thomas Deneke at Heart Center, Bad Neustadt, Germany. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the […]

XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy

Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders […]

InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation

Ongoing Trial to Evaluate Optimal Dose Selected from Dose-Ranging Stage of the INSTANT Study for Rapid Conversion of Atrial Fibrillation to Normal Sinus Rhythm SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced dosing […]

CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer

EDEN PRAIRIE, Minn., Jan. 19, 2021 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo, Jr. to President and Chief Executive Officer (CEO), effective immediately. […]

Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction

Initiation of the Phase 2b FREEDOM trial represents the next step in development of CLBS16 as a potential breakthrough treatment for the millions of sufferers of CMD in the U.S., most of whom are women Patient enrollment underway at The Christ Hospital Health Network in Cincinnati (OH) and Mayo Clinic […]

Teleflex continues to deliver COMPLETE confidence with new Arrow® ErgoPack® Complete MAC, PSI Systems

Teleflex expands value of ErgoPack® Complete enhancements to critical vascular access products WAYNE, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) continues to deliver COMPLETE confidence with the release of the Arrow® ErgoPack® Complete Multi-Lumen Access Catheter (MAC) System and the Arrow® ErgoPack® Complete Percutaneous Sheath Introducer (PSI) System. The release […]

Home-based Heart Monitoring Now Available to All Canadians Through Icentia

Canadian company drives at-home cardiac monitoring nationwide during pandemic QUEBEC CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac […]

Reflow Medical Introduces the Spex™ LP, the Lowest Profile Shapeable Reinforced Support Catheter

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc., a California-based medical device company, introduces the Reflow™ Spex™ LP (Low Profile) 0.014 and 0.018-inch reinforced support catheters. The new Spex LP is engineered to provide the lowest profile tip for accessing and crossing the tightest and most complex lesions with a supportive system. It also […]